No Data
Montage Technology's net profit for 2024 is expected to increase by over 200%. In Q4, multiple data points hit record highs, driven by the AI boom, leading to new product shipments.
Montage Technology expects to achieve a net income of 1.378 billion to 1.438 billion yuan for the fiscal year 2024, representing year-on-year growth of 205.62% to 218.93%; The company announced the launch of its latest developed PCIe 6.x/CXL 3.x Retimer chip, which has been successfully delivered to customers for sampling.
National Silicon Industry Group is expected to make a loss of up to 1 billion yuan in 2024, with the construction of the 300mm silicon wafer capacity upgrade project underway.
① With the rapid development of emerging technologies such as 5G, AI, and the Internet of Things, the demand for semiconductor chips continues to grow, driving an increase in the demand for semiconductor wafers. ② National Silicon Industry Group states that the global semiconductor market scale has significantly grown by 19%, but the market recovery from downstream to upstream requires a certain period, coupled with the industry's high inventory levels, leading to the semiconductor wafer market recovery not meeting expectations.
The semiconductor material manufacturer Xinyi Technology has started the A-share IPO counseling, with Tuojing Technology and Advanced Micro-Fabrication Equipment Inc. China both investing.
① Xinmi Technology has completed the listing counseling filing and intends to go public on the A-shares, with Sinolink serving as the counseling institution; ② The strategic financing completed by Xinmi Technology in May 2023 was jointly invested by the leading domestic film deposition equipment company Tuojing Technology and the leading company in the Semiconductors etching equipment, Advanced Micro-Fabrication Equipment Inc. China.
Firing the first shot for increased computing power! Driven by CPU and DCU, Haiguang Information's annual report shows net profit may increase by nearly 60%.
① Haiguang Information expects to achieve revenue of 8.72 billion to 9.53 billion yuan in 2024, a year-on-year increase of 45.04% to 58.52%; ② Regarding the reasons for performance growth, Haiguang Information stated that the rapid iteration and development of DCU products has achieved support for AI industry applications such as commercial computing.
An alternative "going abroad" for centralized procurement of pharmaceuticals and medical devices? The China-ASEAN regional centralized procurement platform for pharmaceuticals has been launched, and the industry anticipates the birth of the first Order.
① Today, the China-ASEAN pharmaceutical regional procurement platform officially launched, with representatives from Shenzhen Mindray Bio-Medical Electronics, United Imaging Healthcare, SIMCERE PHARMA, and other companies present; ② Although the specific implementation plan is yet to be clarified, the industry believes it is undoubtedly Bullish for domestic pharmaceutical companies; ③ The Southeast Asian pharmaceutical market is growing rapidly, but it relies heavily on imported drugs and medical devices.
Beijing Kingsoft Office Software, Inc CEO Zhang Qingyuan: Let AI become the central nervous system of every enterprise | Voices of AI Leaders ・2025
① In the past year, Beijing Kingsoft Office Software, Inc found the right direction in the field of AI: it should leverage its expertise at the application level, as future AI large models will definitely be implemented through applications; ② In the future, the goal of Beijing Kingsoft Office Software, Inc is to make AI the central nervous system of every enterprise, helping businesses establish their own 'corporate brain.'
